Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2'.
Pennings MT, Derksen RH, van Lummel M, Adelmeijer J, VanHoorelbeke K, Urbanus RT, Lisman T, de Groot PG. Pennings MT, et al. Among authors: vanhoorelbeke k. J Thromb Haemost. 2007 Feb;5(2):369-77. doi: 10.1111/j.1538-7836.2007.02310.x. Epub 2006 Nov 10. J Thromb Haemost. 2007. PMID: 17096706 Free article.
Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C, Hilbert L, Vanhoorelbeke K, Deckmyn H, Goudemand J, Mazurier C. Caron C, et al. Among authors: vanhoorelbeke k. Br J Haematol. 2006 Jun;133(6):655-63. doi: 10.1111/j.1365-2141.2006.06095.x. Br J Haematol. 2006. PMID: 16704443 Free article.
Response to letter regarding article, "plasmin cleavage of von willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy".
Tersteeg C, de Maat S, De Meyer SF, Smeets MW, Barendrecht AD, Roest M, Pasterkamp G, Fijnheer R, Vanhoorelbeke K, de Groot PG, Maas C. Tersteeg C, et al. Among authors: vanhoorelbeke k. Circulation. 2015 Jan 13;131(2):e19-20. doi: 10.1161/CIRCULATIONAHA.114.012802. Circulation. 2015. PMID: 25583061 No abstract available.
Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.
Tersteeg C, Fijnheer R, Pasterkamp G, de Groot PG, Vanhoorelbeke K, de Maat S, Maas C. Tersteeg C, et al. Among authors: vanhoorelbeke k. Semin Thromb Hemost. 2016 Feb;42(1):9-17. doi: 10.1055/s-0035-1564838. Epub 2015 Nov 23. Semin Thromb Hemost. 2016. PMID: 26595154 Review.
Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis.
de Maat S, Clark CC, Barendrecht AD, Smits S, van Kleef ND, El Otmani H, Waning M, van Moorsel M, Szardenings M, Delaroque N, Vercruysse K, Urbanus RT, Sebastian S, Lenting PJ, Hagemeyer CE, Renné T, Vanhoorelbeke K, Tersteeg C, Maas C. de Maat S, et al. Among authors: vanhoorelbeke k. Blood. 2022 Jan 27;139(4):597-607. doi: 10.1182/blood.2021011776. Blood. 2022. PMID: 34752601 Free article.
213 results